BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 28202605)

  • 1. Retraction: Oncogene PKCε controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.
    Niture SK; Gnatt A; Jaiswal AK
    J Cell Sci; 2017 Feb; 130(4):815. PubMed ID: 28202605
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction: Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression.
    Kaspar JW; Niture SK; Jaiswal AK
    J Cell Sci; 2017 Feb; 130(4):814. PubMed ID: 28202604
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.
    Dhakshinamoorthy S; Jaiswal AK
    Oncogene; 2001 Jun; 20(29):3906-17. PubMed ID: 11439354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction: Antioxidant-induced modification of INrf2 cysteine 151 and PKC-δ-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.
    Niture SK; Jain AK; Jaiswal AK
    J Cell Sci; 2017 Feb; 130(4):816. PubMed ID: 28202606
    [No Abstract]   [Full Text] [Related]  

  • 5. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2.
    Sekhar KR; Yan XX; Freeman ML
    Oncogene; 2002 Oct; 21(44):6829-34. PubMed ID: 12360409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
    Mol Cancer Ther; 2018 Nov; 17(11):2491. PubMed ID: 30389813
    [No Abstract]   [Full Text] [Related]  

  • 7. Nrf2 signaling in coordinated activation of antioxidant gene expression.
    Jaiswal AK
    Free Radic Biol Med; 2004 May; 36(10):1199-207. PubMed ID: 15110384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2. A NOVEL MECHANISM IN NRF2 ACTIVATION.
    Jain AK; Mahajan S; Jaiswal AK
    J Biol Chem; 2017 Feb; 292(5):2050. PubMed ID: 28159763
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction: INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
    Niture SK; Jaiswal AK
    Cell Death Differ; 2014 Mar; 21(3):503. PubMed ID: 24336049
    [No Abstract]   [Full Text] [Related]  

  • 10. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway.
    Perletti GP; Concari P; Brusaferri S; Marras E; Piccinini F; Tashjian AH
    Oncogene; 1998 Jun; 16(25):3345-8. PubMed ID: 9681835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothymosin-α mediates nuclear import of the INrf2/Cul3·Rbx1 complex to degrade nuclear Nrf2.
    Niture SK; Jaiswal AK
    J Biol Chem; 2017 Feb; 292(5):2049. PubMed ID: 28159762
    [No Abstract]   [Full Text] [Related]  

  • 13. PI 3 kinase-dependent Akt kinase and PKCepsilon independently regulate interferon-gamma-induced STAT1alpha serine phosphorylation to induce monocyte chemotactic protein-1 expression.
    Venkatesan BA; Mahimainathan L; Ghosh-Choudhury N; Gorin Y; Bhandari B; Valente AJ; Abboud HE; Choudhury GG
    Cell Signal; 2006 Apr; 18(4):508-18. PubMed ID: 16157472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression.
    Batarseh A; Giatzakis C; Papadopoulos V
    Biochemistry; 2008 Dec; 47(48):12886-99. PubMed ID: 18975922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of insulin resistance and beta-cell loss by abrogating PKCepsilon-induced serine phosphorylation of muscle IRS-1 in Psammomys obesus.
    Mack E; Ziv E; Reuveni H; Kalman R; Niv MY; Jörns A; Lenzen S; Shafrir E
    Diabetes Metab Res Rev; 2008 Oct; 24(7):577-84. PubMed ID: 18613220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PKCε downregulation on autophagy in glioblastoma cells.
    Toton E; Romaniuk A; Konieczna N; Hofmann J; Barciszewski J; Rybczynska M
    BMC Cancer; 2018 Feb; 18(1):185. PubMed ID: 29439667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barbituric acid derivative BAS 02104951 inhibits PKCε, PKCη, PKCε/RACK2 interaction, Elk-1 phosphorylation in HeLa and PKCε and η translocation in PC3 cells following TPA-induction.
    Gruber P; Rechfeld F; Kirchmair J; Hauser N; Boehler M; Garczarczyk D; Langer T; Hofmann J
    J Biochem; 2011 Mar; 149(3):331-6. PubMed ID: 21186251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility.
    Ivaska J; Vuoriluoto K; Huovinen T; Izawa I; Inagaki M; Parker PJ
    EMBO J; 2005 Nov; 24(22):3834-45. PubMed ID: 16270034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C epsilon phosphorylates keratin 8 at Ser8 and Ser23 in GH4C1 cells stimulated by thyrotropin-releasing hormone.
    Akita Y; Kawasaki H; Imajoh-Ohmi S; Fukuda H; Ohno S; Hirano H; Ono Y; Yonekawa H
    FEBS J; 2007 Jul; 274(13):3270-85. PubMed ID: 17553064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.